跳至主要内容
临床试验/NCT06831929
NCT06831929招募中不适用

Human Papillomavirus Ends Here: A Multilevel Intervention to Increase Uptake of the HPV Vaccine Among Adolescents

University of California, Davis3 个研究点 分布在 1 个国家目标入组 2,232 人开始时间: 2025年2月28日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
2,232
试验地点
3
主要终点
Primary Outcome: Evaluation

研究概览

简要总结

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

详细描述

The goal of this study is to use an evidence-based approach to develop, implement and evaluate a ML intervention on increasing HPV vaccine uptake among UCDH CP patients ages 10-12.

Aim 1. Refine and finalize a parent, primary care team and clinic ML intervention to increase uptake and completion of the HPV vaccine series among adolescent patients of the UCDH CP practices. In Phase 1, semi-structured qualitative interviews with key stakeholders will be conducted to refine the content and implementation approaches.

Aim 2. Conduct and evaluate the effectiveness and sustainability of the ML intervention. In Phase 2, twelve UCDH CP practices will be recruited to participate in a 2-arm parallel group randomized controlled trial. The primary outcome age-appropriate completion of the HPV vaccine series will be assessed via Epic, the UCDHS electronic medical record (EMR) software. It is hypothesized that patients of clinics in the intervention condition will have significantly higher HPV completion rates compared to patients of clinics in the control condition (usual care).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
10 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine

排除标准

  • Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.

研究组 & 干预措施

Control Arm

No Intervention

These clinics will not receive any intervention and will continue with care as usual.

Intervention Arm

Experimental

These clinics will receive the multilevel intervention which will include tailored parent/patient education, appointment scheduling assistance, and primary care team trainings.

干预措施: Intervention Arm (Behavioral)

结局指标

主要结局

Primary Outcome: Evaluation

时间窗: One year

Number of participants who initiate and complete the HPV vaccine series

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验